Literature DB >> 15503325

Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging.

Young Kon Kim1, Chong Soo Kim, Hyo Sung Kwak, Jeong Min Lee.   

Abstract

PURPOSE: To assess the diagnostic performance of three-dimensional dynamic liver imaging with sensitivity encoding (SENSE), including double arterial phase images and increased resolution, by comparing it to superparamagnetic iron oxide (SPIO)-enhanced magnetic resonance (MR) imaging for the detection of hypervascular hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: Twenty-seven consecutive patients with 50 HCCs underwent Gd-BOPTA-enhanced dynamic imaging using SENSE and SPIO-enhanced MR imaging with at least a 24-hour interval between examinations. Using a three-dimensional gradient-echo technique applying SENSE, dynamic imaging consisting of double arterial phase-, portal phase- and delayed phase-images, was obtained. Using T2-weighted turbo spin-echo and T2*-weighted fast imaging with steady-state precession sequence, SPIO-enhanced MR imaging was obtained. For qualitative analysis, the diagnostic accuracy of both MR examinations for detecting the 50 HCCs was evaluated using the alternative free-response receiver operating characteristic method. Sensitivity and positive predictive value were also evaluated.
RESULTS: The mean sensitivity and positive predictive value of three-dimensional dynamic imaging with SENSE were 91.3% and 89.2%, respectively, and those of SPIO-enhanced imaging were 77.3% and 92.6 %, respectively. There was a significant difference in sensitivity between the two images (P <0.05). The mean Az value of three-dimensional dynamic imaging with SENSE (0.97 +/- 0.01) was significantly higher than that of SPIO-enhanced imaging (0.90 +/- 0.02) (P=0.00).
CONCLUSION: Three-dimensional dynamic liver MR imaging using SENSE for acquiring double arterial phase images is more efficient than SPIO-enhanced MR imaging for detecting HCCs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15503325     DOI: 10.1002/jmri.20188

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  11 in total

1.  Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis.

Authors:  Lorenzo Andreana; Graziella Isgrò; Maria Pleguezuelo; Giacomo Germani; Andrew K Burroughs
Journal:  World J Hepatol       Date:  2009-10-31

2.  Exponential growth of publications on carbon nanodots by Chinese authors.

Authors:  Junqing Wang; Hak Soo Choi; Yì-Xiáng J Wáng
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

3.  Current status of superparamagnetic iron oxide contrast agents for liver magnetic resonance imaging.

Authors:  Yi-Xiang J Wang
Journal:  World J Gastroenterol       Date:  2015-12-21       Impact factor: 5.742

4.  Prospective comparison of high- and low-spatial-resolution dynamic MR imaging with sensitivity encoding (SENSE) for hypervascular hepatocellular carcinoma.

Authors:  Masakatsu Tsurusaki; Richard C Semelka; Kensuke Uotani; Koji Sugimoto; Masahiko Fujii; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2008-04-30       Impact factor: 5.315

Review 5.  Magnetic resonance imaging of the cirrhotic liver: An update.

Authors:  Agnes Watanabe; Miguel Ramalho; Mamdoh AlObaidy; Hye Jin Kim; Fernanda G Velloni; Richard C Semelka
Journal:  World J Hepatol       Date:  2015-03-27

Review 6.  A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging.

Authors:  Yì Xiáng J Wáng; Jean-Marc Idée
Journal:  Quant Imaging Med Surg       Date:  2017-02

7.  Double-dose 1.0-M gadobutrol versus standard-dose 0.5-M gadopentetate dimeglumine in revealing small hypervascular hepatocellular carcinomas.

Authors:  Young Kon Kim; Young Hwan Lee; Chong Soo Kim; Young Min Han; Seung Bae Hwang
Journal:  Eur Radiol       Date:  2007-04-03       Impact factor: 5.315

Review 8.  Hepatobiliary MR imaging with gadolinium-based contrast agents.

Authors:  Alex Frydrychowicz; Meghan G Lubner; Jeffrey J Brown; Elmar M Merkle; Scott K Nagle; Neil M Rofsky; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2012-03       Impact factor: 4.813

9.  Small hypervascular hepatocellular carcinomas: value of "washout" on gadolinium-enhanced dynamic MR imaging compared to superparamagnetic iron oxide-enhanced imaging.

Authors:  Jeong-Sik Yu; Jae-Joon Chung; Joo Hee Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2009-06-10       Impact factor: 5.315

Review 10.  Challenges and opportunities in developing targeted molecular imaging to determine inner ear defects of sensorineural hearing loss.

Authors:  Mohammad N Kayyali; Alexander C Wright; Andrew J Ramsey; Jason A Brant; Joel M Stein; Bert W O'Malley; Daqing Li
Journal:  Nanomedicine       Date:  2017-10-24       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.